179 related articles for article (PubMed ID: 8402501)
21. Association of near-diploid DNA content and N-myc amplification in neuroblastomas.
Dominici C; Negroni A; Romeo A; Castello MA; Clerico A; Scopinaro M; Mauro F; Raschellà G
Clin Exp Metastasis; 1989; 7(2):201-11. PubMed ID: 2920475
[TBL] [Abstract][Full Text] [Related]
22. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
George RE; London WB; Cohn SL; Maris JM; Kretschmar C; Diller L; Brodeur GM; Castleberry RP; Look AT
J Clin Oncol; 2005 Sep; 23(27):6466-73. PubMed ID: 16116152
[TBL] [Abstract][Full Text] [Related]
23. Determination of N-myc gene amplification in neuroblastoma by differential polymerase chain reaction.
Gilbert J; Norris MD; Haber M; Kavallaris M; Marshall GM; Stewart BW
Mol Cell Probes; 1993 Jun; 7(3):227-34. PubMed ID: 8366868
[TBL] [Abstract][Full Text] [Related]
24. DNA content and proliferative activity in children with neuroblastoma.
Yalçin B; Kutluk T; Kansu E; Göğüş S; Canpinar H; Akyüz C; Büyükpamukçu M
Pediatr Hematol Oncol; 2000; 17(1):45-54. PubMed ID: 10689714
[TBL] [Abstract][Full Text] [Related]
25. Flow cytometric nuclear DNA content analysis of renal tumors in children: prognostic significance of nuclear DNA ploidy.
Li P; Yokomori K; Tsuchida Y; Fujita M; Shimizu K; Tanaka E; Pianovski MA; Takemura T
Tumour Biol; 1995; 16(6):385-93. PubMed ID: 7569685
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric DNA analysis of neuroblastoma--clinical significance of DNA tetraploidy.
Naito M; Iwafuchi M; Hirota M
Prog Clin Biol Res; 1994; 385():87-93. PubMed ID: 7972240
[No Abstract] [Full Text] [Related]
27. DNA flow cytometric analysis of neuroblastoma: distinction of tetraploidy subset.
Kusafuka T; Fukuzawa M; Oue T; Yoneda A; Okada A; Satani M
J Pediatr Surg; 1994 Apr; 29(4):543-7. PubMed ID: 8014812
[TBL] [Abstract][Full Text] [Related]
28. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
Kogner P; Barbany G; Björk O; Castello MA; Donfrancesco A; Falkmer UG; Hedborg F; Kouvidou H; Persson H; Raschella G
Prog Clin Biol Res; 1994; 385():137-45. PubMed ID: 7972205
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of proliferating cell nuclear antigen (PCNA) immunostaining in neuroblastoma.
Kawasaki H; Mukai K; Yajima S; Tanaka R; Takayama J; Takasaki Y; Ohira M
Med Pediatr Oncol; 1995 May; 24(5):300-4. PubMed ID: 7700181
[TBL] [Abstract][Full Text] [Related]
30. Flow cytometric DNA analysis of neuroblastoma: prognostic significance of DNA ploidy in unfavorable group.
Naito M; Iwafuchi M; Ohsawa Y; Uchiyama M; Hirota M; Matsuda Y; Iinuma Y
J Pediatr Surg; 1991 Jul; 26(7):834-7. PubMed ID: 1895194
[TBL] [Abstract][Full Text] [Related]
31. Correlation between the number of segmental chromosome aberrations and the age at diagnosis of diploid neuroblastomas without MYCN amplification.
Souzaki R; Tajiri T; Teshiba R; Kinoshita Y; Yosue R; Kohashi K; Oda Y; Taguchi T
J Pediatr Surg; 2011 Dec; 46(12):2228-32. PubMed ID: 22152855
[TBL] [Abstract][Full Text] [Related]
32. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
[TBL] [Abstract][Full Text] [Related]
33. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma.
Norris MD; Bordow SB; Marshall GM; Haber PS; Cohn SL; Haber M
N Engl J Med; 1996 Jan; 334(4):231-8. PubMed ID: 8532000
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric analysis of DNA content in children with neuroblastoma.
Brenner DW; Barranco SC; Winslow BH; Shaeffer J
J Pediatr Surg; 1989 Feb; 24(2):204-7. PubMed ID: 2724014
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
36. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
Shimada H; Stram DO; Chatten J; Joshi VV; Hachitanda Y; Brodeur GM; Lukens JN; Matthay KK; Seeger RC
J Natl Cancer Inst; 1995 Oct; 87(19):1470-6. PubMed ID: 7674334
[TBL] [Abstract][Full Text] [Related]
37. N-myc amplification in neuroblastomas: histopathological, DNA ploidy, and clinical variables.
Oppedal BR; Oien O; Jahnsen T; Brandtzaeg P
J Clin Pathol; 1989 Nov; 42(11):1148-52. PubMed ID: 2584426
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analysis of N-myc protein expression in neuroblastoma: correlation with prognosis of patients.
Hiyama E; Hiyama K; Yokoyama T; Ishii T
J Pediatr Surg; 1991 Jul; 26(7):838-43. PubMed ID: 1895195
[TBL] [Abstract][Full Text] [Related]
39. N-myc oncogene and urinary catecholamines in children with neuroblastoma.
Barontini M; Gutiérrez MI; Levin G; Mur N; Diez B
Med Pediatr Oncol; 1993; 21(7):499-504. PubMed ID: 8341218
[TBL] [Abstract][Full Text] [Related]
40. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M
J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
